In the beginning of CKD, FGF-23 attenuates vascular calcification, preventing an increase in serum phosphate levels, while FGF-23 is unable to sustain normal phosphate levels in end-stage renal disease. The gene discussed is FGF23; the disease is stage 5 chronic kidney disease.